Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Annals of the Rheumatic Diseases

Ab1717 Guidance for Stem Cell Therapy for Juvenile Systemic Sclerosis Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

IFIvan FoeldvariKTKathryn S. TorokJSJoão Silva

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Foeldvari et al. (2024) studied this question.

synapsesocial.com/papers/68e6706fb6db6435875fb461https://doi.org/10.1136/annrheumdis-2024-eular.2264
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1OP0212 HIGHDOSE CHEMOTHERAPY AND TRANSPLANTATION OF 34+ SELECTED STEM CELLS FOR PROGRESSIVE SYSTEMIC SCLEROSIS WITH OR WITHOUT CARDIAC INVOLVEMENT OR ALVEOLITIS - MODIFICATION ACCORDING TO MANIFESTATION (AST MOMA)2024
  2. 2AB1142 DERMAL CELLULAR SENESCENCE AND ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN PATIENTS WITH SYSTEMIC SCLEROSIS TREATED WITH CYCLOPHOSPHAMIDE OR AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION2024
  3. 3AB1372 PEDIATRIC AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TREATMENT-RESISTANT AUTOIMMUNE DISEASES: A REAL-LIFE SINGLE-CENTER EXPERIENCE2024 · 1 citations
  4. 4P0627Outcomes of autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s Disease: a single-center retrospective case series2026
  5. 5Autologous stem cell transplantation (ASCT) for Refractory juvenile-onset systemic sclerosis (JSSc)2026